Welcome to Our Blog

Subscribe below to get free access to our latest newsletter and watch our product video

Leveraging Patient-Focused Drug Development by Social Media Patient Listening Studies

Patients are experts in their own experience of a disease or condition. They are also the end consumers of medical products....


( read )

Tags: Semalytix, AI, Healthcare,

Are you listening? Patients will tell you what a good drug looks like.

Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...


( read )

Tags: Semalytix, "patient listening", "Health"

What the pharmaceutical industry can learn from online conversations about healthcare

People talk about everything online – including health. The pharmaceutical industry can pay attention. The start-up Semalytix...


( read )
White Paper: AI-Powered Real-World Evidence Generation

Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders

Executive Summary


( read )

Tags: Paper, Semalytix, AI

How machines can measure the real impact of new therapies

By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences


( read )

Tags: Semalytix

Semalytix’ Knowledge Graph featured at the Neo4J Meeting „GraphTalk: Health & Life Sciences“ in Basel

The knowledge graph developed by Semalytix comprises of millions of pharma-relevant entities modeling key knowledge about...


( read )

Tags: Semalytix

Pharma Pricing & Market Access (PPMA) Conference Learnings

Looking at Market Access for the pharmaceutical industry through the eyes of somebody involved in machine learning and...


( read )

Tags: Semalytix

Paper on „Zero-Shot Cross-Lingual Opinion Target Extraction“ at NAACL 2019

At Semalytix, we are developing cutting-edge technology for machine reading, allowing machines to automatically sift through...


( read )

Tags: Semalytix